ASCO 2018: How Cardiac Imaging, Biomarkers Could Improve Cancer Patient Care | Latest News RSS feed

ASCO 2018: How Cardiac Imaging, Biomarkers Could Improve Cancer Patient Care - Latest News


ASCO 2018 Highlights: GI and Hepatic Toxicities of Immune Checkpoint Inhibitor Therapy

As part of our coverage of the 2018 American Society of Clinical Oncology ... T cells can cross-react with host antigens and cause a variety of immune-related adverse events. Cancer Network: In ... read more

Merck Increases Focus on Advanced Prostate Cancer, Expanding Immuno-Oncology Program with Three New Phase 3 Trials

“These promising data presented at ASCO ... may increase the risk of rejection in solid organ transplant recipients. Consider the benefit of treatment vs the risk of possible organ rejection in these ... read more

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker on Q1 2018 Results - Earnings Call Transcript

The data show a significant correlation between overall tumor biomarker response and the achievement of the primary cardiovascular ... TTC in patients with metastatic castrate-resistant prostate ... read more

Looking for another news?


Meet the ‘preeminent AI company on earth,’ but can it succeed in healthcare?

In cardiac ultrasound ... the medical imaging supercomputer Meanwhile, many paragraphs ago I noted that Nvidia is involved in at least two efforts that could radically alter the world of radiology and ... read more


In NYC and Around the Country, Racial Skew Hampers Trials for New Medicines and Treatments

He is vice chair of medical oncology at Montefiore/Einstein Center for Cancer ... patients to see a cardiologist. The question of risk Almost all things medical involve some risk. Medicines carry side ... read more

Merck Highlights Breadth of Immuno-Oncology Research Program in Genitourinary Cancers at ASCO GU

In October 2018 ... KEYTRUDA may increase the risk of rejection in solid organ transplant recipients. Consider the benefit of treatment vs the risk of possible organ rejection in these patients. ... read more

How advanced nanotechnology can improve cancer care

We emphasize the idea of developing personalized nanocarriers based on the type of cancer and its biomarker ... will also increase the likelihood of successful treatment. "The field continues to offer ... read more

Breast Cancer Patients Receiving Anthracycline Chemotherapy and Trastuzumab Have Biventricular Dysfunction and Reduced Heart Mass

Numerous cancer ... and oncology clinicians in an effort to better understand how cardiovascular complications develop for cancer patients, improve detection, and determine how they can be effectively ... read more

Navidea Biopharmaceuticals' (NAVB) Interim CEO Jed Latkin on Q2 2018 Results - Earnings Call Transcript

Further, they indicated that the size of the approval study in humans could be fewer than 10 patients ... health care investors look for. We've been able to make some nice announcements about some ... read more

Imaging with CMR can improve detection of cardiac injury in lupus patients

Study allows non-invasive diagnosis A study by the University Hospital Frankfurt in collaboration with partners from London and Tübingen has shown that imaging with cardiac magnetic resonance (CMR) ... read more

Preventing Today's Survivors of Breast Cancer From Becoming Tomorrow's Cardiac Patients

The comanagement of cardiovascular disease and breast cancer can be a ... This may increase cancer health disparities for patients treated at community hospitals and in underserved areas. It will be ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us